Mizuho MedyLtd 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Fuminari Karakawa

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	47yrs
CEO 소유권	36.7%
경영진 평균 재임 기간	14.6yrs
이사회 평균 재임 기간	12.7yrs

최근 관리 업데이트

Recent updates

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Aug 06

CEO

Fuminari Karakawa (79 yo)

47yrs

테뉴어

Mr. Fuminari Karakawa founded MIZUHO MEDY Co., Ltd. in November 1977 and serves as its President and Representative Director since November 1977. Mr. Karakawa serves as the Chairman of the Board at MIZUHO...

리더십 팀

이름	위치	테뉴어	보상	소유권
Fuminari Karakawa	Chairman of the Board & President	47yrs	데이터 없음	36.69% ¥ 11.4b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	14.6yrs	데이터 없음	0.22% ¥ 66.9m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	데이터 없음	0.074% ¥ 22.9m
Tadashi Imamura	MD, Technology Supervisor	no data	데이터 없음	0.43% ¥ 133.9m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	no data	데이터 없음	0.48% ¥ 149.1m
Kenji Narahara	Manager of Development Department and Director	no data	데이터 없음	0.54% ¥ 166.5m

14.6yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 관리: 4595 의 관리팀은 노련하고 경험 (평균 재직 기간 14.6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Fuminari Karakawa	Chairman of the Board & President	47yrs	데이터 없음	36.69% ¥ 11.4b
Hiroshi Sasaki	GM of Accounting Department & General Affairs Department and Director	13.7yrs	데이터 없음	0.22% ¥ 66.9m
Toshio Kamihara	General Manager of Sales Division & Overseas Business Department and Director	9.7yrs	데이터 없음	0.074% ¥ 22.9m
Tadashi Imamura	MD, Technology Supervisor	14.7yrs	데이터 없음	0.43% ¥ 133.9m
Kazuhiro Ichimaru	Manager of Intellectual Property Department & Director	13.7yrs	데이터 없음	0.48% ¥ 149.1m
Kenji Narahara	Manager of Development Department and Director	11.7yrs	데이터 없음	0.54% ¥ 166.5m
Katsumi Sasaki	Independent External Director	9.7yrs	데이터 없음	0.028% ¥ 8.7m
Nobuhiko Shigemi	External Auditor	13.7yrs	데이터 없음	0.019% ¥ 6.0m
Takakichi Hashimoto	External Auditor	9.7yrs	데이터 없음	0.021% ¥ 6.4m
Hirotaka Kawasaki	Chairman of Board of Corporate Auditors	5.7yrs	데이터 없음	0.34% ¥ 105.3m

12.7yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: 4595 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12.7 년).

Mizuho MedyLtd 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

No independent directors

No independent directors

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Recent updates

Third quarter 2024 earnings released: EPS: JP¥27.85 (vs JP¥143 in 3Q 2023)

Mizuho Medy Co.,Ltd. to Report Q3, 2024 Results on Nov 08, 2024

Second quarter 2024 earnings released: EPS: JP¥54.49 (vs JP¥75.07 in 2Q 2023)

Mizuho Medy Co.,Ltd.'s (TSE:4595) Earnings Are Not Doing Enough For Some Investors

Upcoming dividend of JP¥80.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2024 Results on Aug 09, 2024

First quarter 2024 earnings released: EPS: JP¥102 (vs JP¥78.33 in 1Q 2023)

Mizuho Medy Co.,Ltd. to Report Q1, 2024 Results on May 10, 2024

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 28, 2024

Full year 2023 earnings released: EPS: JP¥396 (vs JP¥823 in FY 2022)

Now 21% undervalued

Inaugural dividend of JP¥140 per share

Mizuho Medy Co.,Ltd. to Report Q4, 2023 Results on Feb 09, 2024

Third quarter 2023 earnings released: EPS: JP¥143 (vs JP¥308 in 3Q 2022)

Investor sentiment improves as stock rises 16%

Mizuho Medy Co.,Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment improves as stock rises 19%

Price target decreased by 23% to JP¥2,400

Second quarter 2023 earnings released: EPS: JP¥75.07 (vs JP¥135 in 2Q 2022)

Mizuho Medy Co.,Ltd. to Report Q2, 2023 Results on Aug 10, 2023

Inaugural dividend of JP¥40.00 per share

First quarter 2023 earnings released: EPS: JP¥78.33 (vs JP¥201 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥823 (vs JP¥506 in FY 2021)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 29, 2023

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 10, 2023

Inaugural dividend of JP¥160 per share

Price target decreased to JP¥2,500

No independent directors

Third quarter 2022 earnings released: EPS: JP¥308 (vs JP¥187 in 3Q 2021)

Mizuho Medy Co.,Ltd. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥135 (vs JP¥173 in 2Q 2021)

Investor sentiment improved over the past week

Inaugural dividend of JP¥50.00 per share

Mizuho Medy Co.,Ltd. to Report Q2, 2022 Results on Aug 10, 2022

First quarter 2022 earnings released: EPS: JP¥201 (vs JP¥68.35 in 1Q 2021)

No independent directors

Mizuho Medy Co.,Ltd. to Report Q1, 2022 Results on May 09, 2022

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 30, 2022

Inaugural dividend of JP¥95.00 per share

Third quarter 2021 earnings released: EPS JP¥187 (vs JP¥8.29 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥173 (vs JP¥9.45 loss in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS JP¥68.35 (vs JP¥0.32 loss in 1Q 2020)

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd. to Report Q1, 2021 Results on May 10, 2021

New 90-day high: JP¥2,653

Full year 2020 earnings released: EPS JP¥32.13 (vs JP¥91.76 in FY 2019)

Mizuho Medy Co.,Ltd., Annual General Meeting, Mar 26, 2021

Investor sentiment improved over the past week

New 90-day high: JP¥1,565

First Dividend Is JP¥6.00 Per Share

Mizuho Medy Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

New 90-day low: JP¥1,307

Price target raised to JP¥1,500

Mizuho Medy Co.,Ltd. to Report Q3, 2020 Results on Nov 09, 2020

Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령